» Articles » PMID: 8625295

Distinct Areas of Allelic Loss on Chromosomal Regions 10p and 10q in Human Prostate Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 1996 May 15
PMID 8625295
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Utilizing tissue microdissection and PCR techniques, we have examined 35 prostate tumors paired with normal tissues from the same patients for allelic loss at 24 polymorphic loci spanning chromosome 10. Twenty-five tumors (71%) were deleted for at least one chromosome 10 locus. Of the total 35 tumors, 6 (17%) were deleted for 10p loci only, 5 (14%) for 10q loci only, and 14 (40%) were deleted for both 10p and 10q loci. The common region of deletion on 10p included loci D10S211-D10S89-D10S111. Fluorescence in situ hybridization of yeast artificial chromosome probes encompassing these loci demonstrated that the 10p region of deletion maps to 10p11.2. Losses involving 10p loci alone were most common in localized (5/14, 36%) and least common in metastatic (0/8) tumors. The common region of deletion on 10q included loci D10S219-D10S215, consistent with the major region of deletion recently defined for prostate tumors on 10q. Losses involving 10q loci alone were lowest in localized and locally invasive tumors (1/14 and 2/12, respectively) and highest in tumors metastatic to regional lymph nodes (2/8). These results suggest that 10p losses may define less invasive tumors, whereas 10q losses may play a role in the progression to more advanced tumor states in the prostate. Furthermore, this is the first report of allelic loss of a defined region on 10p potentially harboring tumor suppressor gene loci in human prostate cancer.

Citing Articles

Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.

Rozen E, Shohet J Cancer Metastasis Rev. 2021; 41(1):33-52.

PMID: 34716856 PMC: 8924100. DOI: 10.1007/s10555-021-10001-7.


Targeting Splicing in Prostate Cancer.

Antonopoulou E, Ladomery M Int J Mol Sci. 2018; 19(5).

PMID: 29693622 PMC: 5983716. DOI: 10.3390/ijms19051287.


Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy.

Wu J, Yu E Cancer Metastasis Rev. 2014; 33(2-3):607-17.

PMID: 24414227 PMC: 4096322. DOI: 10.1007/s10555-013-9482-0.


Chronic chlorpyrifos exposure does not promote prostate cancer in prostate specific PTEN mutant mice.

Svensson R, Bannick N, Marin M, Robertson L, Lynch C, Henry M J Environ Pathol Toxicol Oncol. 2013; 32(1):29-39.

PMID: 23758150 PMC: 3951157. DOI: 10.1615/jenvironpatholtoxicoloncol.2013006778.


KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.

Huh S, Chen Y, Friedman S, Liao J, Huang H, Cavenee W J Natl Cancer Inst. 2010; 102(15):1131-47.

PMID: 20660366 PMC: 2914760. DOI: 10.1093/jnci/djq218.